Skip to main content

Table 1 The MCM6 mRNA relative expression and clinical information of 31 neuroblastoma tissue samples

From: MCM6 indicates adverse tumor features and poor outcomes and promotes G1/S cell cycle progression in neuroblastoma

 

MCM6 expression

Total

P value

Low

High

  

Sex

   

0.071

 Male

8

10

18

 Female

10

3

13

Age at diagnosis

   

0.008

  ≤ 18 m

1

6

7

  > 18 m

17

7

24

Stage

   

0.484

 I, II, IVs

2

4

6

 III, IV

8

8

16

Primary site

   

0.768

 Retroperitoneum

5

3

10

 Postmediastinum

13

10

21

Hisopathology diagnosis

   

0.000

 GN

8

1

9

 GNB

8

0

8

 NB

2

12

14

Bone marrow metastasis

   

0.841

 Positive

2

1

3

 Negative

17

11

28

Risk

   

0.396

 Low

11

5

16

 Mid

3

1

4

 High

5

6

11

  1. The value is displayed as the number of cases. NB neurobastoma, GNB ganglioeuroblastoma, GN ganglioneuroma
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us